Navigation Links
First Response Partners With Fertility Expert Zita West to Support Those Trying for a Baby
Date:10/25/2011

LONDON, October 26, 2011 /PRNewswire/ --

Pinktimeline.com launched as a resource for the '2 week wait'

Church & Dwight UK, the makers of First Response, and Zita West, fertility expert and midwife to the stars, have teamed up to offer support to those trying for a baby. First Response has announced the launch of a new website, http://www.pinktimeline.com, which is a resource for those trying for a baby, especially during the '2-week wait.'

"The 2-week wait, the time between ovulation and the time to test, is a time of great uncertainty for many women while they are waiting to test and they are hoping to see a positive pregnancy test showing those two pink lines. As a midwife, I'm often asked about what lifestyle changes need to be made at this stage. Women can visit pinktimeline.com for tips on little steps that can lead to a healthier you and a healthier pregnancy," said Zita West.

Pinktimeline.com provides details on what is happening to a woman's body during this time and includes Zita's tips for staying healthy and relaxed. There is even a forum where women can connect with others who are also waiting to test. After testing, there is a results page with next step advice from Zita.

The website also offers a bespoke fundraising section to assist couples in raising funds for costs associated with trying for a baby; such as specialty consultations or fertility treatments.

Couples can create a private fundraising page to share with family and friends, at their discretion, to help them raise funds. The fundraising page will be particularly useful around birthdays and holidays, as a way for couple's to share their story and ask for donations in place of gifts.

No one likes to wait, especially when it's for such a life-changing answer. Why wait longer than you have to? First Response can tell you first. First Response Early Pregnancy Test is so sensitive that most pregnant women have enough of the pregnancy hormone, hCG (human chorionic gonadotropin), to be detected as early as 6 days before a missed period, and a day before other tests.[1]

First Response products include the First Response Early Pregnancy Test and First Response Easy-Read Ovulation Test.

Please visit http://www.pinktimeline.com and http://www.firstresponsefertility.com for more information.

1. In clinical testing, First Response detected hormone levels consistent with pregnancy in 62% of women, 6 days before the day of missed period, in 78% of women 5 days before the day of missed period, in 87% of women 4 days before the day of missed period and in 98% of women 3 days before the day of missed period and over 99% of women 2 days before the day of missed period.


For more information please contact
First Response Press Office
Lexis PR
Contact: Ann-Marie Bannan/Sophie Mackey
Email: abannan@lexispr.com / smackey@lexispr.com
Tel: +44-(0)20-7908-6496 / +44-(0)20-7908-6431


'/>"/>
SOURCE First Response
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Olympus Introduces Worlds First Autoclavable 5mm HD Deflectable Videolaparoscope
2. Top Plastic Surgeon Introduces Worlds First VECTRA XT 3D Imaging Solution
3. NORTHWEST BIO Announces Initiation of S&P Coverage, With Publication of First Company Stock Report
4. Mylan Launches First Generic Version of Exelon® Capsules in the U.K.
5. Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results
6. FDA Approves First Generic Olanzapine to Treat Schizophrenia, Bipolar Disorder
7. Clarient Joins the HistoRx® Clinical Trials Network: First Commercial Lab to Provide Aqua® Technology for Clinical Trials
8. Arthrosurface Launches Worlds First Talus Resurfacing Implant for the Ankle
9. Chindex International, Inc. to Report Financial Results for the Third Quarter and First Nine Months of 2011
10. Accuray Incorporated to Report Financial Results for First Quarter of Fiscal 2012
11. NeuroSigma Funds First-Ever Pediatric Clinical Trial to Study Non-Invasive External Trigeminal Nerve Stimulation for the Treatment of ADHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Mass. , April 20, 2017  RXi ... developing innovative therapeutics that address significant unmet medical ... data from the Company,s consumer product development program, ... at the Society for Investigative Dermatology (SID) 76 ... to advance and promote the sciences relevant to ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
(Date:4/20/2017)... Research and Markets has announced the addition of ... By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, ... to their offering. ... The Latin American pharmaceutical contract manufacturing services market is anticipated ... drug registration cost in Latin American countries and continuous economic ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... Ridgecrest Herbals makes it a point to lead ... reduce waste, and support renewable energy. They believe this is a crucial part of ... solutions for health issues, and maintain that destroying the environment in the pursuit of ...
(Date:4/24/2017)... ... ... , a national non-profit organization focusing on the prevention and early detection of breast and ... to announce Katie Thiede as their new Chief Executive Officer. In January, founder Lindsay Avner ... Board and launched a national search to find a visionary new leader to grow Bright ...
(Date:4/24/2017)... ... April 24, 2017 , ... The John P. McGovern Museum of Health and ... to track their cognitive health, and share results with their physicians. Members and guests ... the museum's website. , BrainCheck founder, Dr. David Eagleman, formerly at Baylor College of ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... within the telehealth industry, announces the company’s VideoMedicine mobile platform has launched Quick ... Available 24 hours a day, Quick Care provides patients with the option to ...
(Date:4/24/2017)... ... April 24, 2017 , ... MAP Health Management announced today ... people with addiction who are served by MAP’s patient engagement ecosystem. Lief Therapeutics ... monitors heart and breath rates to identify anxiety levels and can provide biofeedback ...
Breaking Medicine News(10 mins):